Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-18 Sale | 2026-08-20 7:05 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 186 | $71.98 | $13,388 | 9,570 (Direct) | View |
| 2026-06-30 Sale | 2026-07-02 7:06 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 5,681 | $70 | $397,670 | 9,756 (Direct) | View |
| 2026-06-15 Sale | 2026-06-17 7:12 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 5,538 | $60.71 | $336,212 | 15,437 (Direct) | View |
| 2026-05-19 Sale | 2026-05-21 6:26 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 199 | $65.51 | $13,036 | 20,975 (Direct) | View |
| 2026-02-18 Sale | 2026-02-20 7:10 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 180 | $73 | $13,140 | 21,174 (Direct) | View |
| 2026-01-20 Sale | 2026-01-22 7:31 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 3,867 | $35.67 | $137,936 | 21,354 (Direct) | View |
| 2025-11-25 Sale | 2025-11-25 8:30 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 1,157 | $54.28 | $62,802 | 23,737 (Direct) | View |
| 2025-09-04 Sale | 2025-09-08 8:32 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 1,721 | $33.52 | $57,693 | 17,462 (Direct) | View |
| 2025-09-02 Sale | 2025-09-04 9:02 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 485 | $30.1 | $14,599 | 19,183 (Direct) | View |
| 2025-08-19 Sale | 2025-08-21 9:05 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 725 | $26.59 | $19,278 | 36,334 (Direct) | View |
| 2025-05-19 Sale | 2025-05-21 8:08 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 10,712 | $0.67 | $7,177 | 305,892 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 6:07 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 10,300 | $1.01 | $10,403 | 316,604 (Direct) | View |
| 2024-12-19 Sale | 2024-12-20 8:33 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 51,115 | $0.94 | $48,048 | 326,904 (Direct) | View |
| 2024-11-19 Sale | 2024-11-20 8:37 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 7,785 | $1.01 | $7,863 | 243,019 (Direct) | View |
| 2024-08-19 Sale | 2024-08-20 9:15 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 6,866 | $1.28 | $8,788 | 250,804 (Direct) | View |
| 2024-05-17 Sale | 2024-05-20 9:13 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 7,355 | $1.75 | $12,871 | 257,670 (Direct) | View |
| 2024-02-20 Sale | 2024-02-22 8:19 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 9,014 | $0.68 | $6,130 | 265,025 (Direct) | View |
| 2023-11-17 Sale | 2023-11-20 9:02 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 9,646 | $0.49 | $4,727 | 274,039 (Direct) | View |
| 2023-08-16 Sale | 2023-08-17 8:08 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 9,703 | $0.78 | $7,568 | 283,685 (Direct) | View |
| 2023-05-16 Sale | 2023-05-17 8:29 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 9,791 | $0.72 | $7,050 | 293,388 (Direct) | View |
| 2023-02-16 Sale | 2023-02-17 9:00 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 10,484 | $3 | $31,452 | 303,179 (Direct) | View |
| 2022-11-16 Sale | 2022-11-18 6:05 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 13,460 | $3.57 | $48,052 | 313,663 (Direct) | View |
| 2022-08-18 Sale | 2022-08-19 6:27 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 73,716 | $4.65 | $342,779 | 327,123 (Direct) | View |
| 2022-08-16 Sale | 2022-08-17 7:41 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 10,560 | $4.76 | $50,266 | 670,839 (Direct) | View |
| 2022-05-16 Sale | 2022-05-17 9:40 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 21,673 | $3.95 | $85,608 | 276,399 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 6:20 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 10,912 | $10.95 | $119,486 | 274,122 (Direct) | View |
| 2021-11-16 Sale | 2021-11-17 6:11 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 20,869 | $13.16 | $274,636 | 232,084 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-24 Option Award | 2026-07-24 6:35 pm | N/A 2032-12-12 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 16,500 | $0 | 16,500 (Direct) | View |
| 2025-12-22 Option Award | 2025-12-23 6:01 pm | N/A 2033-12-21 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 31,250 | $0 | 50,221 (Direct) | View |
| 2025-11-21 Option Award | 2025-11-25 8:30 pm | N/A 2028-12-17 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 7,432 | $0 | 23,737 (Direct) | View |
| 2025-08-19 Option Award | 2025-08-21 9:05 pm | N/A 2031-12-12 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 16,666 | $0 | 36,334 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 8:55 pm | N/A 2030-08-14 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 780,000 | $0 | 1,023,019 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 6:07 pm | N/A 2031-12-12 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2022-08-15 Option Award | 2022-08-17 7:41 pm | N/A 2030-08-14 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 405,000 | $0 | 670,839 (Direct) | View |
| 2022-05-15 Option Award | 2022-05-17 9:40 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 23,950 | $0 | 276,399 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-20 8:28 pm | N/A 2029-12-15 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 146,950 | $0 | 379,034 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 6:11 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 40,150 | $0 | 232,084 (Direct) | View |
| 2021-10-12 Option Award | 2021-10-14 9:10 pm | N/A 2027-12-11 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 71,550 | $0 | 71,550 (Direct) | View |